European Life Sciences Review: Issue 2

March 2016

Welcome to the second issue of our European Life Sciences Review that covers some of the most critical developments in the pharmaceutical and medical technology sectors in the last month and is produced by our life sciences lawyers in London, Frankfurt, and Paris.

In this issue, we cover updates relating to:

  • Brexit—23 June 2016 Referendum
  • Safety
  • Orphan Medicines 
  • Clinical Research
  • Promotion
  • Related Product Areas
  • Market Access and Reimbursement
  • Intellectual Property
  • Morgan Lewis Update

Read the second issue of the
European Life Sciences Review >>